Efficacy of oral colchicine with intralesional hyaluronidase or triamcinolone acetonide in the Grade II oral submucous fibrosis
Authors:
Open Access
- 1 January 2017
- journal article
- research article
- Published by Medknow in National Journal of Maxillofacial Surgery
- Vol. 8 (1) , 50-54
Abstract
Background and Objectives: Oral submucous fibrosis (OSMF) is a potentially malignant disorder of oral mucosa affecting mainly population in South and Southeast Asia. The aim of this study is to compare the effectiveness of oral colchicine with intralesional injection of hyaluronidase or injection triamcinolone acetonide in patients with Grade II OSMF. Materials and Methods: The study included thirty patients of clinically diagnosed Grade II OSMF. Patients were divided randomly into two groups: Group A patients were treated by administrating tablet colchicine 0.5 mg twice daily with an intralesional injection of hyaluronidase 1500 IU with 0.5 ml of lignocaine hydrochloride at weekly interval for 12 weeks. Group B patients were treated by administering tablet colchicine 0.5 mg twice daily with an intralesional injection of triamcinolone acetonide 10 mg/ml at weekly interval for 12 weeks. Clinical diagnosis was based on burning sensation in mouth, blanching of mucosa, presence of vesicles or ulceration in oral cavity, and reduced mouth opening. Outcome assessment was done at intervals of 3 weeks, 6 weeks, 3 months, and 6 months. Results: Improvement in mouth opening and reduction in burning sensation was seen more in Group A patients. Improvement in blanching of mucosa was seen in both the groups. Conclusion: In conclusion, use of injection hyaluronidase with oral colchicine gave better results in terms of increase in mouth opening and improvement in burning sensation without notable side effects. However, for a definite conclusion, further study with large sample size and long follow-up is required.Keywords
This publication has 24 references indexed in Scilit:
- Role of TGF-β and BMP7 in the pathogenesis of oral submucous fibrosisGrowth Factors, 2011
- A systematic review of medical interventions for oral submucous fibrosis and future research opportunitiesOral Diseases, 2011
- Efficacy of alpha lipoic acid in adjunct with intralesional steroids and hyaluronidase in the management of oral submucous fibrosisJournal of Cancer Research and Therapeutics, 2010
- Oral submucous fibrosis: Review on aetiology and pathogenesisOral Oncology, 2006
- Oral submucous fibrosis: a case‐control study in Chennai, South IndiaJournal of Oral Pathology & Medicine, 2004
- Etiology of oral submucous fibrosis with special reference to the role of areca nut chewingJournal of Oral Pathology & Medicine, 1995
- Role of areca nut in the causation of oral submucous fibrosis: a case‐control study in PakistanJournal of Oral Pathology & Medicine, 1994
- Management of oral submucous fibrosis: A conservative approachJournal of Oral and Maxillofacial Surgery, 1991
- Oral submucous fibrosis—A new treatment regimenJournal of Oral and Maxillofacial Surgery, 1988
- Colchicine. New uses of an old, old drugArchives of Dermatology, 1982